Tirzepatide (GLP-2 TRZ)

Dual-agonist research peptide studied for advanced metabolic and weight-regulation pathways.

Tirzepatide, sometimes referred to as GLP-2 TRZ, is a next-generation investigational peptide studied as a dual incretin receptor agonist with activity at both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. These two pathways play a central role in metabolic signaling, appetite regulation, and glucose homeostasis, making Tirzepatide a major focus of contemporary metabolic research.

In preclinical and clinical research settings, Tirzepatide has been extensively studied for its potential role in body-weight regulation, glycemic control, appetite signaling, and overall metabolic efficiency. Research models have consistently examined how simultaneous activation of GLP-1 and GIP receptors may produce synergistic metabolic effects that exceed those observed with GLP-1–only compounds, positioning Tirzepatide as a key comparator in next-generation incretin research.

Scientific literature has further explored Tirzepatide’s activity in relation to significant improvements in insulin sensitivity, reductions in circulating glucose markers, and favorable changes in metabolic biomarkers when compared to selective GLP-1 agonists. These findings have driven continued interest in Tirzepatide as a reference compound in studies evaluating dual-pathway approaches to metabolic and obesity-related research.

Another defining feature of Tirzepatide is its extended biological half-life, which has been studied for its ability to sustain receptor engagement over prolonged periods in research models. This characteristic makes GLP-2 TRZ particularly valuable in longitudinal metabolic, endocrine, and energy-balance investigations, where consistent signaling over time is a critical variable.

Because of its well-characterized dual-agonist mechanism, strong body of published research, and relevance to weight-regulation and metabolic disease studies, Tirzepatide has become one of the most widely utilized investigational peptides in modern metabolic research.

This product is supplied as a high-purity lyophilized powder, suitable for controlled laboratory handling and long-term storage when maintained under appropriate conditions.

Specifications

• Compound: Tirzepatide (GLP-2 TRZ)

• Form: Lyophilized powder

• Storage: Store in a cool, dry environment. Protect from moisture, heat, and direct light.

Common Research Focus Areas

• Weight-regulation and obesity research models

• Appetite signaling and energy balance studies

• GLP-1 and GIP receptor pathway analysis

• Insulin sensitivity and glucose metabolism research

• Comparative evaluation of dual- versus single-agonist incretin compounds

Research Use Only

This material is supplied exclusively for laboratory research use. Not for human or animal consumption. Purchase and use are restricted to qualified researchers or research institutions operating in compliance with all applicable laws and regulations.